Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Maven Brands Inc TRLFF


Primary Symbol: C.MJ

Maven Brands Inc. is a Canada-based licensed processor serving the burgeoning craft cannabis community in Canada with a full suite of production, processing, and packaging solutions. The Company, through its subsidiary, Maven Cannabis, owns and operates an approximately 19,500 square foot cannabis facility at the 40-acre Monashee Gateway Business Park, situated in the Village of Lumby at the... see more

CSE:MJ - Post Discussion

Maven Brands Inc > Weed The People Movie.
View:
Post by West898 on Jan 16, 2019 1:38am

Weed The People Movie.

That was an awesome movie! To think the US government have registered US patents for medical uses for marijuana since 2003 for degenerative diseases but big Pharma keeps blocking the US from allowing that medicine. https://www.uspatent6630507.com/
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities